Join us on 12-15-2022 for a live seminar about RNA SEQ

Click Here
Learn more

Better medicine, together

Through a community of partners, we democratize access to foundational, pre-competitive biologics discovery technologies and services.

We empower discovery across 6 biologic modalities

We support the drug discovery industry with 3 core activities across 6 biologic modalities

We empower drug discovery across 6 biologic modalities with our platforms, services, and company creation

We’ve grown from our original platform for human monoclonal antibody discovery, the ATX-Gx™, to support a spectrum of biologics. Discovery groups can find the best drug against their target and develop innovative new therapeutic formats.

We aggregate, improve, co-develop, and outlicense foundational precompetitive drug discovery platform technologies. 

We provide services and capabilities to discover therapeutic drug candidates for our partners.

We collaborate to build new asset-focused companies leveraging this expertise and infrastructure.

We develop, improve, license, and share foundational, pre-competitive drug discovery platform technologies. We provide services and support to discover therapeutic drug candidates for our partners and the broader ecosystem. We collaborate to build new, asset-focused companies leveraging our expertise and infrastructure and support innovative ecosystem partners who share our mission.

ANTIBODIES
TCRS
GENETIC MEDICINES
PEPTIDES
CELL THERAPIES
DELIVERY
antibody drug discovery
ANTIBODIES
TCR drug discovery
TCRS
ASO genetic medicines discovery
GENETIC MEDICINES
ANTIBODIES
TCRS
GENETIC MEDICINES
peptides drug discovery
PEPTIDES
Cell therapies
CELL THERAPIES
biologics drug delivery
DELIVERY
PEPTIDES
CELL THERAPIES
DELIVERY
Our ecosystem model transforms drug discovery

We are a biotechnology ecosystem company

We offer our technologies and capabilities to the entire drug discovery community—from academic scientists, small and medium biotech, to the largest biopharma—on affordable, non-exclusive terms. This network of drug discovery teams creates innovations and shares services that are widely available through collaboration to benefit all.

See case studies

We make foundational drug discovery capabilities and technologies available to all

We reinvest 100% of our revenue into innovation and access to innovation to continually improve our offering for partners. Access our offerings through:

PLATFORM LICENSES

DISCOVERY SERVICES

INNOVATION SUBSCRIPTIONS

License pre-competitive tech without restrictions

Join the over 130 companies already working one or more of Alloy’s technologies. We develop, improve, license, and share foundational, pre-competitive discovery platforms and offer broad access to the global drug discovery community, including other CROs who can support your drug discovery efforts. We have active research and collaborations across our six modalities and currently offer broad access to our first two modalities: Antibodies and TCRs.
Talk with Business Development

Dig into:

Antibody Platforms
TCR Platforms

Drug discovery & optimization services

If you need help beyond your current internal or CRO capabilities, we have built one of the world’s best discovery services team conducting dozens of high-touch, bespoke therapeutic discovery campaigns per year across Alloy’s 5 global research sites. We can work with you in a custom and fully integrated drug discovery approach that deploys our complete offering of proprietary in vivo, in vitro and in silico discovery platforms combined with advanced analytics, antigen generation, functional assay, informatics, and machine learning capabilities to discover the best therapeutic candidate against your target of interest.
Get started

Explore:

DeepImmune Antibody Discovery
Keyway TCR Discovery
Translational Medicine

All the tech you need, one fixed price

We envision a future where all Big Pharma can access cutting-edge innovations in real-time and royalty-free to unlock the potential of internal drug discovery teams in all companies. Our best companies shouldn’t have to wait 20 years for patents to expire to get unfettered access to the newest pre-competitive platforms and technologies. Alloy’s Innovation Subscriptions give unlimited access to all our current and forthcoming technology, for a one-stop solution to your discovery challenges. Combined with our commitment to reinvesting 100% of our revenue back into innovation and access to innovation, this creates a powerful flywheel of innovation for all Innovation Subscription partners.
Let's discuss Innovation Subscriptions
Pre-Competitive Tech
Unlimited Access
Fixed Annual Fee

Case studies: How we help

There is no one-size-fits-all engagement with Alloy. We partner flexibly and creatively across each collaboration, activating our stable of platform technologies, discovery services, and company creation capabilities to meet our partners’ goals.

Make medicine together

We empower scientists by democratizing access to foundational tools, technologies, services, and company creation capabilities. We reduce barriers in drug discovery to help the best treatments get to patients—faster. May the best drug win.

SEE OUR MISSION FROM FOUNDER & CEO, ERRIK B. ANDERSON
Your consent is required to display this content from vimeo - Accept Privacy Settings Here

Watch our mission video.

We’ll work with you to meet your discovery goals

By design, our model is concierge and collaborative, just like our name. We will never have our own drug pipeline. We collaborate with our partners to leverage the full potential of our technology and services, as an innovation engine for the drug discovery industry. How can we help you reach your goals?

Heather Schwoebel Alloy Therapeutics Team
Schedule a call with Business Development

On a mission to out-collaborate the world, together

We are a team of 100+ people across 5 research sites, and our work is amplified by our ecosystem of hundreds of companies and thousands of engaged researchers.

Meet our team
Explore openings

We are on a mission to out-collaborate the world, together.

We are a team of 75+ people across 5 research sites, and our work is amplified through our ecosystem of hundreds.

Meet our team
Explore openings
Accept Privacy Settings Here
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please read and Privacy Policy
Youtube
Consent to display content from Youtube
Vimeo
Consent to display content from Vimeo
Google Maps
Consent to display content from Google
Spotify
Consent to display content from Spotify
Sound Cloud
Consent to display content from Sound
Save
We use cookies to enhance your experience while using our website. To learn more about the cookies we use and the data we collect, please read and Accept Privacy Settings Here.
I Accept